$54.8
+2.91
(+5.61%)▲
Insights on Ingevity Corporation
Revenue is down for the last 3 quarters, 481.8M → 371.7M (in $), with an average decrease of 12.0% per quarter
Netprofit is down for the last 4 quarters, 50.7M → -116.8M (in $), with an average decrease of 207.5% per quarter
In the last 1 year, Sherwin-williams Company, The has given 30.8% return, outperforming this stock by 57.0%
In the last 3 years, Linde Plc has given 10.8% return, outperforming this stock by 44.3%
7.66%
Downside
Day's Volatility :7.86%
Upside
0.21%
33.1%
Downside
52 Weeks Volatility :49.37%
Upside
24.32%
Period | Ingevity Corporation | Sector (Materials) | Index (Russel 2000) |
---|---|---|---|
3 Months | 18.47% | 7.2% | 0.0% |
6 Months | 22.7% | 14.9% | 0.0% |
1 Year | -26.19% | 11.7% | 2.1% |
3 Years | -36.82% | 7.3% | -21.9% |
Market Capitalization | 1.7B |
Book Value | $17.43 |
Earnings Per Share (EPS) | -0.15 |
PEG Ratio | 2.05 |
Wall Street Target Price | 57.71 |
Profit Margin | -0.32% |
Operating Margin TTM | 2.1% |
Return On Assets TTM | 5.97% |
Return On Equity TTM | -0.81% |
Revenue TTM | 1.7B |
Revenue Per Share TTM | 46.36 |
Quarterly Revenue Growth YOY | -3.1% |
Gross Profit TTM | 570.1M |
EBITDA | 368.8M |
Diluted Eps TTM | -0.15 |
Quarterly Earnings Growth YOY | -0.65 |
EPS Estimate Current Year | 3.62 |
EPS Estimate Next Year | 5.09 |
EPS Estimate Current Quarter | -0.19 |
EPS Estimate Next Quarter | 0.02 |
What analysts predicted
Upside of 5.31%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 1.1B | ↑ 16.58% |
Net Income | 169.1M | ↑ 33.89% |
Net Profit Margin | 14.92% | ↑ 1.93% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 1.3B | ↑ 14.05% |
Net Income | 183.7M | ↑ 8.63% |
Net Profit Margin | 14.21% | ↓ 0.71% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 1.2B | ↓ 5.94% |
Net Income | 181.4M | ↓ 1.25% |
Net Profit Margin | 14.92% | ↑ 0.71% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 1.4B | ↑ 14.42% |
Net Income | 118.1M | ↓ 34.9% |
Net Profit Margin | 8.49% | ↓ 6.43% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 1.7B | ↑ 19.89% |
Net Income | 211.6M | ↑ 79.17% |
Net Profit Margin | 12.68% | ↑ 4.19% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 1.7B | ↑ 1.47% |
Net Income | -5.4M | ↓ 102.55% |
Net Profit Margin | -0.32% | ↓ 13.0% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 482.0M | ↑ 14.79% |
Net Income | 75.4M | ↑ 26.09% |
Net Profit Margin | 15.64% | ↑ 1.4% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 383.6M | ↓ 20.41% |
Net Income | 15.6M | ↓ 79.31% |
Net Profit Margin | 4.07% | ↓ 11.57% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 392.6M | ↑ 2.35% |
Net Income | 50.7M | ↑ 225.0% |
Net Profit Margin | 12.91% | ↑ 8.84% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 481.8M | ↑ 22.72% |
Net Income | 35.5M | ↓ 29.98% |
Net Profit Margin | 7.37% | ↓ 5.54% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 446.0M | ↓ 7.43% |
Net Income | 25.2M | ↓ 29.01% |
Net Profit Margin | 5.65% | ↓ 1.72% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 371.7M | ↓ 16.66% |
Net Income | -116.8M | ↓ 563.49% |
Net Profit Margin | -31.42% | ↓ 37.07% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 1.3B | ↑ 41.37% |
Total Liabilities | 975.6M | ↑ 49.49% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 2.1B | ↑ 63.05% |
Total Liabilities | 1.6B | ↑ 65.4% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 2.3B | ↑ 8.86% |
Total Liabilities | 1.7B | ↑ 4.56% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 2.5B | ↑ 5.76% |
Total Liabilities | 1.8B | ↑ 6.4% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 2.7B | ↑ 10.83% |
Total Liabilities | 2.0B | ↑ 13.54% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 2.6B | ↓ 4.14% |
Total Liabilities | 2.0B | ↓ 2.27% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 2.3B | ↓ 1.29% |
Total Liabilities | 1.7B | ↓ 0.6% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 2.7B | ↑ 17.17% |
Total Liabilities | 2.0B | ↑ 19.79% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 2.8B | ↑ 1.3% |
Total Liabilities | 2.0B | ↑ 0.41% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 2.8B | ↑ 2.02% |
Total Liabilities | 2.1B | ↑ 3.31% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 2.8B | ↓ 2.17% |
Total Liabilities | 2.0B | ↓ 3.13% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 2.6B | ↓ 5.19% |
Total Liabilities | 2.0B | ↓ 2.74% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 252.0M | ↑ 44.58% |
Investing Cash Flow | -414.4M | ↑ 607.17% |
Financing Cash Flow | 153.7M | ↓ 365.92% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 275.7M | ↑ 9.4% |
Investing Cash Flow | -658.3M | ↑ 58.86% |
Financing Cash Flow | 369.2M | ↑ 140.21% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 352.4M | ↑ 27.82% |
Investing Cash Flow | -110.6M | ↓ 83.2% |
Financing Cash Flow | -50.2M | ↓ 113.6% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 293.0M | ↓ 16.86% |
Investing Cash Flow | -140.6M | ↑ 27.12% |
Financing Cash Flow | -133.1M | ↑ 165.14% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 313.1M | ↑ 6.86% |
Investing Cash Flow | -553.9M | ↑ 293.95% |
Financing Cash Flow | 48.1M | ↓ 136.14% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 100.1M | ↑ 10.61% |
Investing Cash Flow | -86.1M | ↑ 203.17% |
Financing Cash Flow | -71.6M | ↓ 51.29% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 98.2M | ↓ 1.9% |
Investing Cash Flow | -409.2M | ↑ 375.26% |
Financing Cash Flow | 313.0M | ↓ 537.15% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 5.2M | ↓ 94.7% |
Investing Cash Flow | 1.9M | ↓ 100.46% |
Financing Cash Flow | -5.6M | ↓ 101.79% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 48.4M | ↑ 830.77% |
Investing Cash Flow | -23.4M | ↓ 1331.58% |
Financing Cash Flow | -34.5M | ↑ 516.07% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 106.9M | ↑ 120.87% |
Investing Cash Flow | -34.8M | ↑ 48.72% |
Financing Cash Flow | -53.3M | ↑ 54.49% |
Sell
Neutral
Buy
Ingevity Corporation is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Ingevity Corporation | 12.39% | 22.7% | -26.19% | -36.82% | -49.35% |
Air Products & Chemicals Inc. | -0.98% | -18.0% | -18.84% | -18.16% | 14.37% |
Lyondellbasell Industries N.v. | -4.47% | 8.22% | 8.24% | -7.74% | 15.77% |
Linde Plc | -4.06% | 13.59% | 19.61% | 53.31% | 145.23% |
Sherwin-williams Company, The | -9.17% | 23.65% | 30.82% | 9.15% | 101.03% |
Ecolab Inc. | -1.09% | 31.47% | 29.09% | -0.87% | 22.06% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Ingevity Corporation | 13.66 | NA | 2.05 | 3.62 | -0.01 | 0.06 | NA | 17.43 |
Air Products & Chemicals Inc. | 22.57 | 22.57 | 1.37 | 12.31 | 0.15 | 0.05 | 0.03 | 66.91 |
Lyondellbasell Industries N.v. | 15.55 | 15.55 | 1.8 | 8.26 | 0.16 | 0.06 | 0.05 | 39.85 |
Linde Plc | 35.22 | 35.22 | 2.65 | 15.52 | 0.15 | 0.06 | 0.01 | 82.33 |
Sherwin-williams Company, The | 32.35 | 32.35 | 4.16 | 11.43 | 0.72 | 0.1 | 0.01 | 13.88 |
Ecolab Inc. | 46.09 | 46.09 | 2.33 | 6.39 | 0.18 | 0.06 | 0.01 | 23.46 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Ingevity Corporation | Buy | $1.7B | -49.35% | 13.66 | -0.32% |
Air Products & Chemicals Inc. | Buy | $52.5B | 14.37% | 22.57 | 18.82% |
Lyondellbasell Industries N.v. | Hold | $32.8B | 15.77% | 15.55 | 5.14% |
Linde Plc | Buy | $213.7B | 145.23% | 35.22 | 18.87% |
Sherwin-williams Company, The | Buy | $77.2B | 101.03% | 32.35 | 10.52% |
Ecolab Inc. | Hold | $63.1B | 22.06% | 46.09 | 8.96% |
BlackRock Inc
Vanguard Group Inc
Inclusive Capital Partners LP
Wellington Management Company LLP
Victory Capital Management Inc.
State Street Corporation
ingevity is a performance chemicals and materials company dedicated to advancing technologies in oilfield, pavement, carbon and industrial markets that improve daily living. our innovations enable oil to flow better. they help crops grow fuller. they make roads last longer. and they ensure that the air we all breathe is cleaner. there is no customer challenge that our creative and resourceful teams will not take on and solve. by bringing together our high performing people, products and processes, we work together to purify, protect and enhance the world around us, driving exponential results.
Organization | Ingevity Corporation |
Employees | 1700 |
CEO | Mr. John C. Fortson |
Industry | All Other Miscellaneous Chemical Product and Preparation Manufacturing |